CXCL8 and cystic fibrosis: Findings of our study show that iPA inhibits the inflammatory response reducing IL-8 and RANTES production through a mechanism of action involving primarily the downregulation of the NFκB and STAT3 pathways in a CF cell model characterized by exacerbated inflammation.